Related Experiment Video
Updated: Aug 16, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death
Hans Skvara1, Christiane Thallinger, Volker Wacheck
1Department of Radiotherapy and Radiobiology, University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Background:
Anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and Bcl-x, can modulate radio- and/or chemosensitivity of human malignancies. Since no information is available on the role Mcl-1 may play in the radioresponse of tumor cells, the relationship between Mcl-1 expression and response to ionizing radiation (IR) was investigated using an antisense strategy.
Materials And Methods:
Human melanoma cells were treated with Mcl-1 antisense oligonucleotides (ASOs) and IR. The effects of antisense treatment alone or in combination with IR on proliferation, induction of apoptosis and clonogenic cell death were evaluated.
Results:
ASO treatment in combination with IR reduced the mean cell numbers 9.5-fold compared to a 2.6-fold reduction after ASO treatment alone and a 1.6- fold reduction after IR alone. The percentages of apoptosis measured (means +/- SD) were 49% +/- 3.0 in antisense/IR-treated cultures compared to 1.3% +/- 0.5, 14.3% +/- 0.5, 7.3% +/- 1.1 and 10.3% +/- 0.6 in ASO controls, in antisense-treated, in IR-treated and in antisense control plus IR-treated cells, respectively. Colony formation assays demonstrated a synergistic effect of Mcl-1 down-regulation with IR.
Conclusion:
Mcl-1 expression affects the radioresistance of human melanoma cells.
Insights
Mcl-1 (myeloid cell leukemia 1) protein expression increases radioresistance in human melanoma cells. Down-regulating Mcl-1 with antisense oligonucleotides enhances cell death when combined with ionizing radiation.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Anti-apoptotic Bcl-2 family proteins, like Bcl-2 and Bcl-x, influence cancer treatment sensitivity.
- The role of Mcl-1 (myeloid cell leukemia 1) in tumor cell response to ionizing radiation (IR) was previously unknown.
Purpose of the Study:
- To investigate the relationship between Mcl-1 expression and the radioresponse of human melanoma cells.
- To determine if Mcl-1 plays a role in radioresistance.
Main Methods:
- Human melanoma cells were treated with Mcl-1 antisense oligonucleotides (ASOs) and IR.
- Evaluated effects on proliferation, apoptosis, and clonogenic cell death.
Main Results:
- Combined ASO treatment and IR reduced cell numbers 9.5-fold, significantly more than ASO or IR alone.
- Apoptosis increased to 49% in combined treatment groups versus controls.
- Colony formation assays showed a synergistic effect between Mcl-1 down-regulation and IR.
Conclusions:
- Mcl-1 expression significantly impacts the radioresistance of human melanoma cells.
- Targeting Mcl-1 may enhance the efficacy of radiotherapy for melanoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
